HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fehrs, L J Articles by Henneman, C Search for Related Content PubMed PubMed Citation Articles by Fehrs, L J Articles by Henneman, C

Targeted HIV screening at a Los Angeles prenatal/family planning health center.

L J Fehrs, D Hill, P R Kerndt, T P Rose and C Henneman

Division of Immunization, Centers for Disease Control, Atlanta, GA 30333.

In 1988, the Los Angeles County Health Department conducted a blinded human immunodeficiency virus (HIV) seroprevalence study at a public prenatal (PN) and family planning (FP) center serving mostly Hispanic women in order to determine seroprevalence and to evaluate the center's targeted HIV screening program. Four women (0.13 percent) tested positive (3/1801 PN and 1/1167 FP). Three reported no risk factors; one reported a history of syphilis since 1978. Voluntary HIV testing was selectively offered to women who reported risk factors for HIV infection. Only 14 percent (96/685) of clients offered testing chose to do it: 28 percent (14/50) of clients classified as being at highest risk of infection, and 27 percent (16/59) of women who judged themselves to have some chance of being exposed to HIV. None of the four women who tested positive by blinded testing chose testing. While few women at this center were infected with HIV, higher risk women were not persuaded to be tested through a targeted screening program. Blinded HIV seroprevalence studies provide a tool for both tracking infection in a population and evaluating screening programs.

This article has been cited by other articles:

				D. K. Owens, V. Sundaram, L. C. Lazzeroni, L. R. Douglass, G. D. Sanders, K. Taylor, R. VanGroningen, V. M. Shadle, V. C. McWhorter, T. Agoncillo, et al. Prevalence of HIV Infection Among Inpatients and Outpatients in Department of Veterans Affairs Health Care Systems: Implications for Screening Programs for HIV Am J Public Health, December 1, 2007; 97(12): 2173 - 2178. [Abstract] [Full Text] [PDF]

				R. Chou, A. K. Smits, L. H. Huffman, R. Fu, and P. T. Korthuis Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 5, 2005; 143(1): 38 - 54. [Abstract] [Full Text] [PDF]

				S. L. Sansom, D. J. Jamieson, P. G. Farnham, M. Bulterys, and M. G. Fowler Human Immunodeficiency Virus Retesting During Pregnancy: Costs and Effectiveness in Preventing Perinatal Transmission Obstet. Gynecol., October 1, 2003; 102(4): 782 - 790. [Abstract] [Full Text] [PDF]